Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment.

Health Care Utilization and Costs After Initiating Budesonide/Formoterol Combination or Fluticasone/Salmeterol Combination Among COPD Patients New to ICS/LABA Treatment. J Manag Care Spec Pharm. 2016 Mar; 22(3):293-304.

View in: PubMed

subject areas

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists
Aged
Asthma
Bronchodilator Agents
Budesonide
Drug Therapy, Combination
Female
Fluticasone-Salmeterol Drug Combination
Formoterol Fumarate
Health Care Costs
Humans
Male
Middle Aged
Patient Acceptance of Health Care
Pulmonary Disease, Chronic Obstructive
Retrospective Studies
United States

authors with profiles

Charlie B. Strange